Anti-inflammatory diet for breast cancer patients on hormone therapy
Part of Cancer, Skin clinical trials.
This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 45 and 70 years old and have gone through menopause.
- You have been diagnosed with stage I to IIIa breast cancer that is ER-positive and HER2-negative.
- You have been taking an aromatase inhibitor (like anastrozole, letrozole, or exemestane) for 6 to 30 months after surgery.
- Your body mass index (BMI) is between 20 and 34.9.
- You do not have serious health conditions like other cancers, heart disease, autoimmune diseases, or allergies to fish, fish oil, nuts, or certain plant oils.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.
This study tests whether taking tart cherry and omega-3 supplements can help reduce joint pain and stiffness caused by aromatase inhibitors (a common breast cancer treatment). If you have bothersome joint pain while on this hormone therapy, you may be able to join.
This study tests a new approach using a special diet combined with a medication to see if it can improve the effectiveness of hormone therapy for women with ER-positive, HER2-negative metastatic breast cancer. The trial will help determine if this diet can slow cancer growth and potentially delay the need for chemotherapy.
This study tests whether taking omega-3 fish oil supplements (a type of healthy fat) alongside standard breast cancer treatment can help make the treatment work better. You'd take the supplements while receiving chemotherapy, hormone therapy, or other cancer drugs your doctor already planned for you.
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.